Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
Giuseppe Curigliano(European Institute of Oncology), Uwe G. Liebert(Leipzig University), Corinne Faivre‐Finn(National Health Service), Olivier Michielin(SIB Swiss Institute of Bioinformatics), Josep Tabernero(Universitat de Vic - Universitat Central de Catalunya), George Pentheroudakis(University of Ioannina), John B.A.G. Haanen(B. J. Medical College & Sassoon Hospital), Eudald Felip(University of Ioannina), Fátima Cardoso(Université Paris Cité), Paolo A. Ascierto(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Ravindran Kanesvaran(University of Ioannina), S.B. Kim(Royal Marsden NHS Foundation Trust), Pasi A. Jänne(Dana-Farber Cancer Institute), Jean-Yves Douillard(European Society for Medical Oncology), Pilar Garrido(Instituto Cajal), Toni K. Choueiri(Dana-Farber Cancer Institute), Dirk De Ruysscher(University of Ioannina), Rob Glynne‐Jones(Mount Vernon Cancer Centre), Rafał Dziadziuszko(Gdańsk Medical University), Rebecca Dent(National Cancer Centre Singapore), Karin Jordan(OhioHealth), Elisabeth G.E. de Vries(University Medical Center Groningen), Nathan I. Cherny, Solange Peters(University Hospital of Lausanne), Alfredo Addeo, Susana Banerjee(Royal Marsden NHS Foundation Trust), Laurence Albigès(Institut Gustave Roussy), Melvin L.K. Chua(Duke-NUS Medical School), Iris F. Chaberny, E. de Azambuja(University of Ioannina), M.C. Garassino(Fondazione IRCCS Istituto Nazionale dei Tumori), Fabrice Barlési(Institut Gustave Roussy), Carlos Caldas(Université Libre de Bruxelles), Nicolas Girard(Memorial Sloan Kettering Cancer Center), F. Lordick(Leipzig University), E. Hamilton(University of Ioannina), Andrés Cervantes(Universitat de València), Jean-Pascal Machiels(Cliniques Universitaires Saint-Luc), Carmen Criscitiello(University of Milan), V. Golfinopoulos(Universitat de València), Domenico D’Ugo(University of Ioannina)
Cited by 313
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
The Immune Landscape of Cancer
|Immunity|2018|6.2k